Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

February 4, 2026

Phraxis Begins Postapproval Study of EndoForce Anastomotic Connector

February 4, 2026—Phraxis Inc. announced the initiation of its postapproval study (PAS) for the EndoForce anastomotic connector.

The company advised that the first procedure was performed by Ari Kramer, MD, who led a multidisciplinary clinical team specialized in advanced vascular access at Spartanburg Regional Healthcare System in Spartanburg, South Carolina.

According to Phraxis, the EndoForce PAS is designed to validate real-world performance and refine procedural techniques, specifically targeting the graft-to-vein outflow anastomosis—long considered the primary failure point in arteriovenous grafts.

In May 2025, the company announced FDA approval of the EndoForce connector for endovascular venous anastomosis for dialysis access in patients with end-stage renal disease.

Advertisement

February 4, 2026

CHOICE2 Trial Evaluates Intra-Arterial Alteplase Use After Thrombectomy

left-arrow Created with Sketch. Previous Article

February 3, 2026

Dr. Isabel Newton Named CMO for Boston Scientific’s Interventional Oncology and Embolization Business

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)